Pulmonary arterial hypertension in women;Hypertension artérielle pulmonaire féminine

Revue des Maladies Respiratoires

Volumn 25, Issue 4, 2008, Pages 451-460

  Sanchez, O ^a,b   Marie E ^a   Lerolle, U ^a   Wermert, D ^a   Israel Biet D ^a   Meyer, G ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b NONE   (France)

Author keywords

Diagnosis; Pregnancy; Pulmonary arterial hypertension; Treatment

Indexed keywords

ANTIVITAMIN K; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC GMP; DESOGESTREL; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; HEPARIN; NITRIC OXIDE; PROSTACYCLIN; SILDENAFIL; WARFARIN;

ANTICOAGULANT THERAPY; CARDIOPULMONARY HEMODYNAMICS; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTRACEPTION; DISEASE CLASSIFICATION; DIURETIC THERAPY; EXERCISE TOLERANCE; FEMALE; FETUS RISK; GENETIC COUNSELING; GENETIC RISK; HUMAN; OXYGEN THERAPY; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL DIAGNOSIS; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW;

EID: 44249097069     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(08)71585-7     Document Type: Article

References (51)

1. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A : Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004 ; 43 : 5S-12S.
2. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G : Pulmonary arterial hypertension in France : results from a national registry. Am J Respir Crit Care Med 2006 ; 173 : 1023-30.
3. D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, Levy PS, Pietra GG, Reid LM, Reeves JT, Rich S, Vreim CE, Williams GW, Wu M : Survival in patients with primary pulmonary hypertension. Results from a national prospective study. Ann Intern Med 1991 ; 115 : 343-9.
4. Loyd JE, Butler MG, Foroud TM, Conneally PM, Phillips JA, 3rd, Newman JH : Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med 1995 ; 152 : 93-7.
5. Loyd JE, Primm RK, Newman JH : Familial primary pulmonary hypertension : clinical patterns. Am Rev Respir Dis 1984 ; 129 : 194-7.
6. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Begaud B : Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med 1996 ; 335 : 609-16.
7. Cottin V : Hypertension artérielle pulmonaire associée aux connectivites. Rev Mal Respir 2006 ; 23 4 : S61-72.
8. Sanchez O, Sitbon O, Garcia G, Jais X, Simonneau G, Humbert M : Pulmonary artery hypertension associated with connective tissue diseases. Presse Med 2003 ; 32 : 789-99.
9. Nunes H, Humbert M, Sitbon O, Morse JH, Deng Z, Knowles JA, Le Gall C, Parent F, Garcia G, Herve P, Barst RJ, Simonneau G : Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2003 ; 167 : 1433-9.
10. Sitbon O, Humbert M, Jais X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Herve P, Simonneau G : Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension. Circulation 2005 ; 111 : 3105-11.
11. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M : Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004 ; 43 : 13S-24S.
12. Smith AM, Jones RD, Channer KS : The influence of sex hormones on pulmonary vascular reactivity : possible vasodilator therapies for the treatment of pulmonary hypertension. Curr Vasc Pharmacol 2006 ; 4 : 9-15.
13. Dresdale DT, Michtom RJ, Schultz M : Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance. Bull N Y Acad Med 1954 ; 30 : 195- 207.
14. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, Knowles JA : Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000 ; 67 : 737-44.
15. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA, 3rd, Loyd JE, Nichols WC, Trembath RC : Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 2000 ; 26 : 81-4.
16. Morse JH, Horn EM, Barst RJ : Hormone replacement therapy : a possible risk factor in carriers of familial primary pulmonary hypertension. Chest 1999 ; 116 : 847.
17. Sztrymf B, Francoual J, Sitbon O, Labrune P, Jambou M, Pous C, Simonneau G, Humbert M : [Clinical, haemodynamic and genetic features of familial pulmonary arterial hypertension.]. Rev Mal Respir 2004 ; 21 : 909-15.
18. Weiss BM, Hess OM : Pulmonary vascular disease and pregnancy : current controversies, management strategies, and perspectives. Eur Heart J. 2000 ; 21 : 104-15.
19. Humbert M, Sitbon O, Simonneau G : Treatment of pulmonary arterial hypertension. N Engl J Med 2004 ; 351 : 1425-36.
20. Yentis SM, Steer PJ, Plaat F : Eisenmenger’s syndrome in pregnancy : maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 1998 ; 105 : 921-2.
21. Smedstad KG, Cramb R, Morison DH : Pulmonary hypertension and pregnancy : a series of eight cases. Can J Anaesth 1994 ; 41 : 502-12.
22. Weiss BM, Zemp L, Seifert B, Hess OM : Outcome of pulmonary vascular disease in pregnancy : a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998 ; 31 : 1650-7.
23. Bonnin M, Mercier FJ, Sitbon O, Roger-Christoph S, Jais X, Humbert M, Audibert F, Frydman R, Simonneau G, Benhamou D : Severe Pulmonary Hypertension during Pregnancy : Mode of Delivery and Anesthetic Management of 15 Consecutive Cases. Anesthesiology 2005 ; 102 : 1133-7.
24. O’Hare R, McLoughlin C, Milligan K, McNamee D, Sidhu H : Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension. Br J Anaesth 1998 ; 81 : 790-2.
25. Weiss BM, Maggiorini M, Jenni R, Lauper U, Popov V, Bombeli T, Spahn DR : Pregnant patient with primary pulmonary hypertension : inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery. Anesthesiology 2000 ; 92 : 1191-4.
26. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, et al : A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996 ; 334 : 296-302.
27. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G : Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005 ; 353 : 2148-57.
28. Olschewski H, Simonneau G, Galiè N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Seeger W : Inhaled Iloprost for Severe Pulmonary Hypertension. N Engl J Med 2002 ; 347 : 322-9.
29. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G : Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002 ; 346 : 896-903.
30. Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ : Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension. A double- blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2002 ; 165 : 800-4.
31. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL : Primary pulmonary hypertension : Natural history and the importance of thrombosis. Circulation 1984 ; 70 : 580-7.
32. Rich S, Kaufmann E, Levy PS : The effect of high doses of calcium- channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992 ; 327 : 76-81.
33. Ginsberg JS, Bates SM : Management of venous thromboembolism during pregnancy. J Thromb Haemost 2003 ; 1 : 1435-42.
34. Easterling TR, Ralph DD, Schmucker BC : Pulmonary hypertension in pregnancy : treatment with pulmonary vasodilators. Obstet Gynecol 1999 ; 93 : 494-8.
35. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, Rainisio M, Simonneau G : Long-term intravenous epoprostenol infusion in primary pulmonary hypertension : prognostic factors and survival. J Am Coll Cardiol 2002 ; 40 : 780-8.
36. Stewart R, Tuazon D, Olson G, Duarte AG : Pregnancy and primary pulmonary hypertension : successful outcome with epoprostenol therapy. Chest 2001 ; 119 : 973-5.
37. Geohas C, McLaughlin VV : Successful management of pregnancy in a patient with eisenmenger syndrome with epoprostenol. Chest 2003 ; 124 : 1170-3.
38. Monnery L, Nanson J, Charlton G : Primary pulmonary hypertension in pregnancy ; a role for novel vasodilators. Br J Anaesth 2001 ; 87 : 295-8.
39. Badalian SS, Silverman RK, Aubry RH, Longo J : Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report. J Reprod Med 2000 ; 45 : 149-52.
40. Bendayan D, Hod M, Oron G, Sagie A, Eidelman L, Shitrit D, Kramer MR : Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol 2005 ; 106 : 1206-10.
41. Elliot CA, Stewart P, Webster VJ, Mills GH, Hutchinson SP, Howarth ES, Bu’lock FA, Lawson RA, Armstrong IJ, Kiely DG : The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J 2005 ; 26 : 168-73.
42. Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ : Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension : a randomised placebo-controlled study. Lancet 2001 ; 358 : 1119-23.
43. McLaughlin VV, Sitbon O, Badesch DB, Barst RJ, Black C, Galie N, Rainisio M, Simonneau G, Rubin LJ : Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J 2005 ; 25 : 244-9.
44. Barst RJ, Langleben D, Badesch D, Frost A, Lawrence EC, Shapiro S, Naeije R, Galie N : Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol 2006 ; 47 : 2049-56.
45. Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, McLaughlin V, Hill N, Tapson VF, Robbins IM, Zwicke D, Duncan B, Dixon RA, Frumkin LR : Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 2004 ; 169 : 441-7.
46. Molelekwa V, Akhter P, McKenna P, Bowen M, Walsh K. Eisenmenger’s syndrome in a 27 week pregnancy--management with bosentan and sildenafil. Ir Med J 2005 ; 98 : 87-8.
47. Wharton J, Strange JW, Moller GM, Growcott EJ, Ren X, Franklyn AP, Phillips SC, Wilkins MR : Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. Am J Respir Crit Care Med 2005 ; 172 : 105-13.
48. Lacassie HJ, Germain AM, Valdes G, Fernandez MS, Allamand F, Lopez H : Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 2004 ; 103 : 1118-20.
49. Thorne S, Nelson-Piercy C, MacGregor A, Gibbs S, Crowhurst J, Panay N, Rosenthal E, Walker F, Williams D, de Swiet M, Guillebaud J : Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care 2006 ; 32 : 75- 81.
50. Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Levesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY : Hormone therapy and venous thromboembolism among postmenopausal women : impact of the route of estrogen administration and progestogens : the ESTHER study. Circulation 2007 ; 115 : 840-5.
51. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, Loyd JE : Screening, early detection, and diagnosis of pulmonary arterial hypertension : ACCP evidence-based clinical practice guidelines. Chest 2004 ; 126 : 14S-34S.